Hayfellergy Tablets

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
12-05-2019

유효 성분:

Xanthium sibiricum, Quantity: 105 mg (Equivalent: Xanthium sibiricum, Qty 525 mg); Angelica dahurica, Quantity: 19.5 mg (Equivalent: Angelica dahurica, Qty 97.5 mg); Forsythia suspensa, Quantity: 20.4 mg (Equivalent: Forsythia suspensa, Qty 102 mg); Schisandra chinensis, Quantity: 12.6 mg (Equivalent: Schisandra chinensis, Qty 63 mg); Magnolia liliflora, Quantity: 54 mg (Equivalent: Magnolia liliflora, Qty 270 mg); Anemarrhena asphodeloides, Quantity: 18 mg (Equivalent: Anemarrhena asphodeloides, Qty 90 mg); Chrysanthemum sinense, Quantity: 12.6 mg (Equivalent: Chrysanthemum sinense, Qty 63 mg); Saposhnikovia divaricata, Quantity: 19.5 mg (Equivalent: Saposhnikovia divaricata, Qty 97.5 mg); Platycodon grandiflorus, Quantity: 12.6 mg (Equivalent: Platycodon grandiflorus, Qty 63 mg); Schizonepeta tenuifolia, Quantity: 12.6 mg (Equivalent: Schizonepeta tenuifolia, Qty 63 mg)

제공처:

Shen Neng Herbal Medicines Group Pty Ltd

약제 형태:

Tablet, sugar coated

구성:

Excipient Ingredients: hydrolysed maize starch; sucrose

관리 경로:

Oral

수업:

Medicine Listed

치료 징후:

Traditionally used in Chinese medicine to Helps enhance/promote healthy blood circulation ; Traditionally used in Chinese medicine to Decrease/reduce/relieve symptoms of hayfever ; Traditionally used in Chinese medicine to Decrease/reduce/relieve symptoms of allergic rhinitis ; Traditionally used in Chinese medicine to Helps decrease/reduce/relieve symptoms of seasonal allergies

제품 요약:

Visual Identification: ;

승인 상태:

Licence status A

승인 날짜:

2002-10-22